COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link

The American Heart Association advised cardiac patients to avoid medications or supplements that could raise blood pressure. Separately, new reviews explore the latest on the angiotensin connection.
Source: WebMD Health - Category: Consumer Health News Source Type: news

Related Links:

Resumo A doen ça de coronavírus 2019 (COVID-19) é uma pandemia global afetando o mundo, estando presente em mais de 1.300.000 pacientes. O COVID-19 age pelo receptor da enzima conversora de angiotensina 2 (ECA2). As comorbidades cardiovasculares são mais frequentes com COVID-19, e cerca 10% de casos desenvolv em miocardite (22% de pacientes críticas). Mais pesquisas serão necessárias para continuar ou descontinuar inibidores de ECA e bloqueadores dos receptores da angiotensina, que são essenciais para hipertensão e insuficiência cardíaca em COVID-1...
Source: Arquivos Brasileiros de Cardiologia - Category: Cardiology Source Type: research
Conditions:   COVID;   Hypertension Interventions:   Diagnostic Test: ABPM;   Diagnostic Test: ECG;   Diagnostic Test: FMD;   Diagnostic Test: PWV;   Diagnostic Test: Rarefaction Sponsors:   NHS Greater Glasgow and Clyde;   University of Glasgow Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
by Stephen P. Wood, MS, ACNP-BC I stood facing the iPad attached to a rolling stand punching in the phone number of the young granddaughter of my intensive care unit patient. He arrived less than twenty-four hours before. I had taken the call the day before from the outside hospital emergency department and the story was grim. This was a seventy-six-year-old male who had acute myeloid leukemia, hypertension, as well as a history of congestive heart failure. He had been sick for the past two days with a fever, a cough and weakness.…
Source: blog.bioethics.net - Category: Medical Ethics Authors: Tags: End of Life Care Featured Posts Health Care Public Health #bioethicsontheground #covid19 #diaryofaplagueyear COVID-19 Source Type: blogs
A 68-year-old man presented to the emergency department of our hospital complaining of high-grade fever for the last 10 days. He was receiving a broad-spectrum antibiotic (Clarithromycin) and an antiviral drug (Oseltamivir) for 3 days prior to admission with no improvement. His medical history included hypertension and well-controlled Type 2 diabetes mellitus, under treatment with oral anti-diabetic agents. Arterial blood gases revealed acute hypoxemic (Type I) respiratory failure. Multiple diffuse infiltrates on both lungs were apparent in his chest X-ray.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: Case Report Source Type: research
Publication date: Available online 30 May 2020Source: Revista Española de Cardiología (English Edition)Author(s): Jorge Nuche, Carmen Pérez-Olivares, Teresa Segura De La Cal, Carmen Jiménez López-Guarch, Fernando Arribas Ynsaurriaga, Pilar Escribano Subías
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
CONCLUSION: Limited data on COVID-19 during preganacy, associated with a wide variation in the methodology make accurate data interpretation difficult. PMID: 32456489 [PubMed - as supplied by publisher]
Source: Hypertension in Pregnancy - Category: OBGYN Tags: Hypertens Pregnancy Source Type: research
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Analysis of 10 studies found COVID-19 patients with underlying CV comorbidities, including CVD and hypertension, had higher risk of in-hospital mortality (OR 4.85, 95% CI 3.07-7.70 and 3.67; 2.31 to 5.83, respectively). Acute cardiac injury may act as a marker of mortality risk,
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
According to this study, green spaces are restorative and boost attention, while viewing concrete worsens attention during tasks. Finding a forest therapy guide The Association of Nature and Forest Therapy trains and certifies forest therapy guides across the world. Guides help people forge a partnership with nature through a series of invitations that allow participants to become attentive to the forest, to deepen their relationship with nature, and allow the natural world to promote healing and well-being. Ultimately, guides support what the forests have to offer us, inviting participants into practices that deepen physi...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Exercise and Fitness Health Mental Health Stress Source Type: blogs
This article discusses the potential mechanisms by which SARS-CoV-2 modulates the RAS and energy metabolism in individuals with obesity and diabetes mellitus. The article aims to highlight the appropriate strategies for combating the COVID-19 pandemic in the clinical setting and emphasize on the areas that require further investigation in relation to COVID-19 infections in patients with obesity and diabetes mellitus, from the viewpoint of endocrinology and metabolism. PMID: 32469255 [PubMed - as supplied by publisher]
Source: American Journal of Physiology. Endocrinology and Metabolism - Category: Physiology Authors: Tags: Am J Physiol Endocrinol Metab Source Type: research
More News: Cardiology | COVID-19 | Health | Heart | Hypertension